Initial Medication Adherence—Review and Recommendations for Good Practices in Outcomes Research: An ISPOR Medication Adherence and Persistence Special Interest Group Report

Abstract Background Positive associations between medication adherence and beneficial outcomes primarily come from studying filling/consumption behaviors after therapy initiation. Few studies have focused on what happens before initiation, the point from prescribing to dispensing of an initial presc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Value in health 2015-07, Vol.18 (5), p.690-699
Hauptverfasser: Hutchins, David S., MHSA, MBA, Zeber, John E., MHA, PhD, Roberts, Craig S., PharmD, MBA, Williams, Allison F., RN, PhD, Manias, Elizabeth, RN, BPharm, MPharm, PhD, Peterson, Andrew M., PharmD, PhD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 699
container_issue 5
container_start_page 690
container_title Value in health
container_volume 18
creator Hutchins, David S., MHSA, MBA
Zeber, John E., MHA, PhD
Roberts, Craig S., PharmD, MBA
Williams, Allison F., RN, PhD
Manias, Elizabeth, RN, BPharm, MPharm, PhD
Peterson, Andrew M., PharmD, PhD
description Abstract Background Positive associations between medication adherence and beneficial outcomes primarily come from studying filling/consumption behaviors after therapy initiation. Few studies have focused on what happens before initiation, the point from prescribing to dispensing of an initial prescription. Objective Our objective was to provide guidance and encourage high-quality research on the relationship between beneficial outcomes and initial medication adherence (IMA), the rate initially prescribed medication is dispensed. Methods Using generic adherence terms, an international research panel identified IMA publications from 1966 to 2014. Their data sources were classified as to whether the primary source reflected the perspective of a prescriber, patient, or pharmacist or a combined perspective. Terminology and methodological differences were documented among core (essential elements of presented and unpresented prescribing events and claimed and unclaimed dispensing events regardless of setting), supplemental (refined for accuracy), and contextual (setting-specific) design parameters. Recommendations were made to encourage and guide future research. Results The 45 IMA studies identified used multiple terms for IMA and operationalized measurements differently. Primary data sources reflecting a prescriber’s and pharmacist’s perspective potentially misclassified core parameters more often with shorter/nonexistent pre- and postperiods (1–14 days) than did a combined perspective. Only a few studies addressed supplemental issues, and minimal contextual information was provided. Conclusions General recommendations are to use IMA as the standard nomenclature, rigorously identify all data sources, and delineate all design parameters. Specific methodological recommendations include providing convincing evidence that initial prescribing and dispensing events are identified, supplemental parameters incorporating perspective and substitution biases are addressed, and contextual parameters are included.
doi_str_mv 10.1016/j.jval.2015.02.015
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1706212706</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1098301515018446</els_id><sourcerecordid>1706212706</sourcerecordid><originalsourceid>FETCH-LOGICAL-c525t-1f3aaeb6718ffa2da04ddedd5e7e1544433a2e875c1d7cf29a549b82b5d835903</originalsourceid><addsrcrecordid>eNp9UkuOEzEQbSEQMwxcgAXykk03_rT7gxBSNIIQaVCiBNaWY1dr3HTbwXbPaHYcgnNwKE6COxlYIMTGVbbfey7Xqyx7TnBBMKle9UV_I4eCYsILTIsUHmTnhNMyL2vGHqYct03O0vlZ9iSEHmNcMcofZ2e0om2dLs-zHytropED-gjaKBmNs2ihr8GDVfDz2_ct3Bi4RdJqtAXlxhGsPqIC6pxHS-c02nipolEQkLFoPcUES_kWAkivrl-jhUWr3Wa9_ecbR-kN-GBCPO53B1BzQSsbEyJEtPRuOiS5g_Pxafaok0OAZ_fxIvv8_t2nyw_51Xq5ulxc5YpTHnPSMSlhX9Wk6TpJtcSl1qA1hxoIL8uSMUmhqbkiulYdbSUv231D91w3jLeYXWQvT7oH775OqQoxmqBgGKQFNwVBalxRQtOaoPQEVd6F4KETB29G6e8EwWL2SfRi9knMPglMRQqJ9OJef9qPoP9QfhuTAG9OAEi_TBZ4EZSZ-6ONBxWFdub_-m__oqvB2NT84QvcQejd5G3qnyAiJILYzZMyDwrhmDRlWbFfQfy81w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1706212706</pqid></control><display><type>article</type><title>Initial Medication Adherence—Review and Recommendations for Good Practices in Outcomes Research: An ISPOR Medication Adherence and Persistence Special Interest Group Report</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Hutchins, David S., MHSA, MBA ; Zeber, John E., MHA, PhD ; Roberts, Craig S., PharmD, MBA ; Williams, Allison F., RN, PhD ; Manias, Elizabeth, RN, BPharm, MPharm, PhD ; Peterson, Andrew M., PharmD, PhD</creator><creatorcontrib>Hutchins, David S., MHSA, MBA ; Zeber, John E., MHA, PhD ; Roberts, Craig S., PharmD, MBA ; Williams, Allison F., RN, PhD ; Manias, Elizabeth, RN, BPharm, MPharm, PhD ; Peterson, Andrew M., PharmD, PhD ; IPSOR Medication Adherence and Persistence Special Interest Group</creatorcontrib><description>Abstract Background Positive associations between medication adherence and beneficial outcomes primarily come from studying filling/consumption behaviors after therapy initiation. Few studies have focused on what happens before initiation, the point from prescribing to dispensing of an initial prescription. Objective Our objective was to provide guidance and encourage high-quality research on the relationship between beneficial outcomes and initial medication adherence (IMA), the rate initially prescribed medication is dispensed. Methods Using generic adherence terms, an international research panel identified IMA publications from 1966 to 2014. Their data sources were classified as to whether the primary source reflected the perspective of a prescriber, patient, or pharmacist or a combined perspective. Terminology and methodological differences were documented among core (essential elements of presented and unpresented prescribing events and claimed and unclaimed dispensing events regardless of setting), supplemental (refined for accuracy), and contextual (setting-specific) design parameters. Recommendations were made to encourage and guide future research. Results The 45 IMA studies identified used multiple terms for IMA and operationalized measurements differently. Primary data sources reflecting a prescriber’s and pharmacist’s perspective potentially misclassified core parameters more often with shorter/nonexistent pre- and postperiods (1–14 days) than did a combined perspective. Only a few studies addressed supplemental issues, and minimal contextual information was provided. Conclusions General recommendations are to use IMA as the standard nomenclature, rigorously identify all data sources, and delineate all design parameters. Specific methodological recommendations include providing convincing evidence that initial prescribing and dispensing events are identified, supplemental parameters incorporating perspective and substitution biases are addressed, and contextual parameters are included.</description><identifier>ISSN: 1098-3015</identifier><identifier>EISSN: 1524-4733</identifier><identifier>DOI: 10.1016/j.jval.2015.02.015</identifier><identifier>PMID: 26297098</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Consensus ; Drug Prescriptions - standards ; good research methodology ; Health Knowledge, Attitudes, Practice ; Humans ; initial compliance ; initial medication adherence ; Internal Medicine ; Medication Adherence ; Outcome Assessment (Health Care) - standards ; Pharmaceutical Services - standards ; Pharmacists - standards ; Practice Patterns, Physicians' - standards ; Research Design - standards ; Terminology as Topic</subject><ispartof>Value in health, 2015-07, Vol.18 (5), p.690-699</ispartof><rights>International Society for Pharmacoeconomics and Outcomes Research (ISPOR)</rights><rights>2015 International Society for Pharmacoeconomics and Outcomes Research (ISPOR)</rights><rights>Copyright © 2015 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c525t-1f3aaeb6718ffa2da04ddedd5e7e1544433a2e875c1d7cf29a549b82b5d835903</citedby><cites>FETCH-LOGICAL-c525t-1f3aaeb6718ffa2da04ddedd5e7e1544433a2e875c1d7cf29a549b82b5d835903</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1098301515018446$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26297098$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hutchins, David S., MHSA, MBA</creatorcontrib><creatorcontrib>Zeber, John E., MHA, PhD</creatorcontrib><creatorcontrib>Roberts, Craig S., PharmD, MBA</creatorcontrib><creatorcontrib>Williams, Allison F., RN, PhD</creatorcontrib><creatorcontrib>Manias, Elizabeth, RN, BPharm, MPharm, PhD</creatorcontrib><creatorcontrib>Peterson, Andrew M., PharmD, PhD</creatorcontrib><creatorcontrib>IPSOR Medication Adherence and Persistence Special Interest Group</creatorcontrib><title>Initial Medication Adherence—Review and Recommendations for Good Practices in Outcomes Research: An ISPOR Medication Adherence and Persistence Special Interest Group Report</title><title>Value in health</title><addtitle>Value Health</addtitle><description>Abstract Background Positive associations between medication adherence and beneficial outcomes primarily come from studying filling/consumption behaviors after therapy initiation. Few studies have focused on what happens before initiation, the point from prescribing to dispensing of an initial prescription. Objective Our objective was to provide guidance and encourage high-quality research on the relationship between beneficial outcomes and initial medication adherence (IMA), the rate initially prescribed medication is dispensed. Methods Using generic adherence terms, an international research panel identified IMA publications from 1966 to 2014. Their data sources were classified as to whether the primary source reflected the perspective of a prescriber, patient, or pharmacist or a combined perspective. Terminology and methodological differences were documented among core (essential elements of presented and unpresented prescribing events and claimed and unclaimed dispensing events regardless of setting), supplemental (refined for accuracy), and contextual (setting-specific) design parameters. Recommendations were made to encourage and guide future research. Results The 45 IMA studies identified used multiple terms for IMA and operationalized measurements differently. Primary data sources reflecting a prescriber’s and pharmacist’s perspective potentially misclassified core parameters more often with shorter/nonexistent pre- and postperiods (1–14 days) than did a combined perspective. Only a few studies addressed supplemental issues, and minimal contextual information was provided. Conclusions General recommendations are to use IMA as the standard nomenclature, rigorously identify all data sources, and delineate all design parameters. Specific methodological recommendations include providing convincing evidence that initial prescribing and dispensing events are identified, supplemental parameters incorporating perspective and substitution biases are addressed, and contextual parameters are included.</description><subject>Consensus</subject><subject>Drug Prescriptions - standards</subject><subject>good research methodology</subject><subject>Health Knowledge, Attitudes, Practice</subject><subject>Humans</subject><subject>initial compliance</subject><subject>initial medication adherence</subject><subject>Internal Medicine</subject><subject>Medication Adherence</subject><subject>Outcome Assessment (Health Care) - standards</subject><subject>Pharmaceutical Services - standards</subject><subject>Pharmacists - standards</subject><subject>Practice Patterns, Physicians' - standards</subject><subject>Research Design - standards</subject><subject>Terminology as Topic</subject><issn>1098-3015</issn><issn>1524-4733</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UkuOEzEQbSEQMwxcgAXykk03_rT7gxBSNIIQaVCiBNaWY1dr3HTbwXbPaHYcgnNwKE6COxlYIMTGVbbfey7Xqyx7TnBBMKle9UV_I4eCYsILTIsUHmTnhNMyL2vGHqYct03O0vlZ9iSEHmNcMcofZ2e0om2dLs-zHytropED-gjaKBmNs2ihr8GDVfDz2_ct3Bi4RdJqtAXlxhGsPqIC6pxHS-c02nipolEQkLFoPcUES_kWAkivrl-jhUWr3Wa9_ecbR-kN-GBCPO53B1BzQSsbEyJEtPRuOiS5g_Pxafaok0OAZ_fxIvv8_t2nyw_51Xq5ulxc5YpTHnPSMSlhX9Wk6TpJtcSl1qA1hxoIL8uSMUmhqbkiulYdbSUv231D91w3jLeYXWQvT7oH775OqQoxmqBgGKQFNwVBalxRQtOaoPQEVd6F4KETB29G6e8EwWL2SfRi9knMPglMRQqJ9OJef9qPoP9QfhuTAG9OAEi_TBZ4EZSZ-6ONBxWFdub_-m__oqvB2NT84QvcQejd5G3qnyAiJILYzZMyDwrhmDRlWbFfQfy81w</recordid><startdate>20150701</startdate><enddate>20150701</enddate><creator>Hutchins, David S., MHSA, MBA</creator><creator>Zeber, John E., MHA, PhD</creator><creator>Roberts, Craig S., PharmD, MBA</creator><creator>Williams, Allison F., RN, PhD</creator><creator>Manias, Elizabeth, RN, BPharm, MPharm, PhD</creator><creator>Peterson, Andrew M., PharmD, PhD</creator><general>Elsevier Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20150701</creationdate><title>Initial Medication Adherence—Review and Recommendations for Good Practices in Outcomes Research: An ISPOR Medication Adherence and Persistence Special Interest Group Report</title><author>Hutchins, David S., MHSA, MBA ; Zeber, John E., MHA, PhD ; Roberts, Craig S., PharmD, MBA ; Williams, Allison F., RN, PhD ; Manias, Elizabeth, RN, BPharm, MPharm, PhD ; Peterson, Andrew M., PharmD, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c525t-1f3aaeb6718ffa2da04ddedd5e7e1544433a2e875c1d7cf29a549b82b5d835903</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Consensus</topic><topic>Drug Prescriptions - standards</topic><topic>good research methodology</topic><topic>Health Knowledge, Attitudes, Practice</topic><topic>Humans</topic><topic>initial compliance</topic><topic>initial medication adherence</topic><topic>Internal Medicine</topic><topic>Medication Adherence</topic><topic>Outcome Assessment (Health Care) - standards</topic><topic>Pharmaceutical Services - standards</topic><topic>Pharmacists - standards</topic><topic>Practice Patterns, Physicians' - standards</topic><topic>Research Design - standards</topic><topic>Terminology as Topic</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hutchins, David S., MHSA, MBA</creatorcontrib><creatorcontrib>Zeber, John E., MHA, PhD</creatorcontrib><creatorcontrib>Roberts, Craig S., PharmD, MBA</creatorcontrib><creatorcontrib>Williams, Allison F., RN, PhD</creatorcontrib><creatorcontrib>Manias, Elizabeth, RN, BPharm, MPharm, PhD</creatorcontrib><creatorcontrib>Peterson, Andrew M., PharmD, PhD</creatorcontrib><creatorcontrib>IPSOR Medication Adherence and Persistence Special Interest Group</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Value in health</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hutchins, David S., MHSA, MBA</au><au>Zeber, John E., MHA, PhD</au><au>Roberts, Craig S., PharmD, MBA</au><au>Williams, Allison F., RN, PhD</au><au>Manias, Elizabeth, RN, BPharm, MPharm, PhD</au><au>Peterson, Andrew M., PharmD, PhD</au><aucorp>IPSOR Medication Adherence and Persistence Special Interest Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Initial Medication Adherence—Review and Recommendations for Good Practices in Outcomes Research: An ISPOR Medication Adherence and Persistence Special Interest Group Report</atitle><jtitle>Value in health</jtitle><addtitle>Value Health</addtitle><date>2015-07-01</date><risdate>2015</risdate><volume>18</volume><issue>5</issue><spage>690</spage><epage>699</epage><pages>690-699</pages><issn>1098-3015</issn><eissn>1524-4733</eissn><abstract>Abstract Background Positive associations between medication adherence and beneficial outcomes primarily come from studying filling/consumption behaviors after therapy initiation. Few studies have focused on what happens before initiation, the point from prescribing to dispensing of an initial prescription. Objective Our objective was to provide guidance and encourage high-quality research on the relationship between beneficial outcomes and initial medication adherence (IMA), the rate initially prescribed medication is dispensed. Methods Using generic adherence terms, an international research panel identified IMA publications from 1966 to 2014. Their data sources were classified as to whether the primary source reflected the perspective of a prescriber, patient, or pharmacist or a combined perspective. Terminology and methodological differences were documented among core (essential elements of presented and unpresented prescribing events and claimed and unclaimed dispensing events regardless of setting), supplemental (refined for accuracy), and contextual (setting-specific) design parameters. Recommendations were made to encourage and guide future research. Results The 45 IMA studies identified used multiple terms for IMA and operationalized measurements differently. Primary data sources reflecting a prescriber’s and pharmacist’s perspective potentially misclassified core parameters more often with shorter/nonexistent pre- and postperiods (1–14 days) than did a combined perspective. Only a few studies addressed supplemental issues, and minimal contextual information was provided. Conclusions General recommendations are to use IMA as the standard nomenclature, rigorously identify all data sources, and delineate all design parameters. Specific methodological recommendations include providing convincing evidence that initial prescribing and dispensing events are identified, supplemental parameters incorporating perspective and substitution biases are addressed, and contextual parameters are included.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>26297098</pmid><doi>10.1016/j.jval.2015.02.015</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1098-3015
ispartof Value in health, 2015-07, Vol.18 (5), p.690-699
issn 1098-3015
1524-4733
language eng
recordid cdi_proquest_miscellaneous_1706212706
source MEDLINE; Elsevier ScienceDirect Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Consensus
Drug Prescriptions - standards
good research methodology
Health Knowledge, Attitudes, Practice
Humans
initial compliance
initial medication adherence
Internal Medicine
Medication Adherence
Outcome Assessment (Health Care) - standards
Pharmaceutical Services - standards
Pharmacists - standards
Practice Patterns, Physicians' - standards
Research Design - standards
Terminology as Topic
title Initial Medication Adherence—Review and Recommendations for Good Practices in Outcomes Research: An ISPOR Medication Adherence and Persistence Special Interest Group Report
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T13%3A49%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Initial%20Medication%20Adherence%E2%80%94Review%20and%20Recommendations%20for%20Good%20Practices%20in%20Outcomes%20Research:%20An%20ISPOR%20Medication%20Adherence%20and%20Persistence%20Special%20Interest%20Group%20Report&rft.jtitle=Value%20in%20health&rft.au=Hutchins,%20David%20S.,%20MHSA,%20MBA&rft.aucorp=IPSOR%20Medication%20Adherence%20and%20Persistence%20Special%20Interest%20Group&rft.date=2015-07-01&rft.volume=18&rft.issue=5&rft.spage=690&rft.epage=699&rft.pages=690-699&rft.issn=1098-3015&rft.eissn=1524-4733&rft_id=info:doi/10.1016/j.jval.2015.02.015&rft_dat=%3Cproquest_cross%3E1706212706%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1706212706&rft_id=info:pmid/26297098&rft_els_id=S1098301515018446&rfr_iscdi=true